JP2023516753A5 - - Google Patents
Info
- Publication number
- JP2023516753A5 JP2023516753A5 JP2022553583A JP2022553583A JP2023516753A5 JP 2023516753 A5 JP2023516753 A5 JP 2023516753A5 JP 2022553583 A JP2022553583 A JP 2022553583A JP 2022553583 A JP2022553583 A JP 2022553583A JP 2023516753 A5 JP2023516753 A5 JP 2023516753A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- patient
- product according
- salt
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025157586A JP2026016375A (ja) | 2020-03-06 | 2025-09-24 | Ｇｌａ遺伝子の突然変異を有する患者におけるファブリー病を治療する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062986297P | 2020-03-06 | 2020-03-06 | |
| US62/986,297 | 2020-03-06 | ||
| PCT/US2021/020984 WO2021178737A1 (en) | 2020-03-06 | 2021-03-05 | Methods of treating fabry disease in patients having a mutation in the gla gene |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025157586A Division JP2026016375A (ja) | 2020-03-06 | 2025-09-24 | Ｇｌａ遺伝子の突然変異を有する患者におけるファブリー病を治療する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023516753A JP2023516753A (ja) | 2023-04-20 |
| JP2023516753A5 true JP2023516753A5 (https=) | 2024-03-14 |
| JP7749572B2 JP7749572B2 (ja) | 2025-10-06 |
Family
ID=75267607
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022553583A Active JP7749572B2 (ja) | 2020-03-06 | 2021-03-05 | Ｇｌａ遺伝子の突然変異を有する患者におけるファブリー病を治療する方法 |
| JP2025157586A Pending JP2026016375A (ja) | 2020-03-06 | 2025-09-24 | Ｇｌａ遺伝子の突然変異を有する患者におけるファブリー病を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025157586A Pending JP2026016375A (ja) | 2020-03-06 | 2025-09-24 | Ｇｌａ遺伝子の突然変異を有する患者におけるファブリー病を治療する方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20230136297A1 (https=) |
| EP (2) | EP4114390B1 (https=) |
| JP (2) | JP7749572B2 (https=) |
| KR (1) | KR20220152547A (https=) |
| CN (1) | CN115427040A (https=) |
| AR (1) | AR122390A1 (https=) |
| AU (1) | AU2021230371A1 (https=) |
| BR (1) | BR112022017881A2 (https=) |
| CA (1) | CA3170718A1 (https=) |
| CL (1) | CL2022002423A1 (https=) |
| DK (1) | DK4114390T3 (https=) |
| ES (1) | ES3013813T3 (https=) |
| FI (1) | FI4114390T3 (https=) |
| HR (1) | HRP20250179T1 (https=) |
| HU (1) | HUE070116T2 (https=) |
| IL (1) | IL296221A (https=) |
| LT (1) | LT4114390T (https=) |
| MX (1) | MX2022011030A (https=) |
| PL (1) | PL4114390T3 (https=) |
| PT (1) | PT4114390T (https=) |
| RS (1) | RS66530B1 (https=) |
| SI (1) | SI4114390T1 (https=) |
| SM (1) | SMT202500072T1 (https=) |
| TW (1) | TW202146020A (https=) |
| WO (1) | WO2021178737A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12594268B2 (en) * | 2018-08-20 | 2026-04-07 | Amicus Therapeutics, Inc. | Methods of treating Fabry disease in patients having a mutation in the GLA gene |
| KR20220044560A (ko) | 2019-08-07 | 2022-04-08 | 아미쿠스 세라퓨틱스, 인코포레이티드 | Gla 유전자에 돌연변이를 갖는 환자에서 파브리 질병을 치료하는 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
| MX2009010557A (es) | 2007-03-30 | 2009-11-19 | Amicus Therapeutics Inc | Metodo para el tratamiento de la enfermedad de fabry que utiliza chaperonas farmacologicas. |
| EP2946785B1 (en) | 2008-02-12 | 2018-10-24 | Amicus Therapeutics, Inc. | Method to predict response to pharmacological chaperone treatment of diseases |
-
2021
- 2021-03-05 AU AU2021230371A patent/AU2021230371A1/en active Pending
- 2021-03-05 FI FIEP21715035.8T patent/FI4114390T3/fi active
- 2021-03-05 SI SI202130266T patent/SI4114390T1/sl unknown
- 2021-03-05 KR KR1020227034499A patent/KR20220152547A/ko active Pending
- 2021-03-05 AR ARP210100575A patent/AR122390A1/es unknown
- 2021-03-05 PT PT217150358T patent/PT4114390T/pt unknown
- 2021-03-05 EP EP21715035.8A patent/EP4114390B1/en active Active
- 2021-03-05 JP JP2022553583A patent/JP7749572B2/ja active Active
- 2021-03-05 WO PCT/US2021/020984 patent/WO2021178737A1/en not_active Ceased
- 2021-03-05 TW TW110107854A patent/TW202146020A/zh unknown
- 2021-03-05 LT LTEPPCT/US2021/020984T patent/LT4114390T/lt unknown
- 2021-03-05 BR BR112022017881A patent/BR112022017881A2/pt unknown
- 2021-03-05 EP EP24217104.9A patent/EP4527454A3/en active Pending
- 2021-03-05 HR HRP20250179TT patent/HRP20250179T1/hr unknown
- 2021-03-05 US US17/909,450 patent/US20230136297A1/en active Pending
- 2021-03-05 CA CA3170718A patent/CA3170718A1/en active Pending
- 2021-03-05 CN CN202180028403.5A patent/CN115427040A/zh active Pending
- 2021-03-05 HU HUE21715035A patent/HUE070116T2/hu unknown
- 2021-03-05 PL PL21715035.8T patent/PL4114390T3/pl unknown
- 2021-03-05 ES ES21715035T patent/ES3013813T3/es active Active
- 2021-03-05 RS RS20250171A patent/RS66530B1/sr unknown
- 2021-03-05 MX MX2022011030A patent/MX2022011030A/es unknown
- 2021-03-05 SM SM20250072T patent/SMT202500072T1/it unknown
- 2021-03-05 IL IL296221A patent/IL296221A/en unknown
- 2021-03-05 DK DK21715035.8T patent/DK4114390T3/da active
-
2022
- 2022-09-06 CL CL2022002423A patent/CL2022002423A1/es unknown
-
2025
- 2025-09-24 JP JP2025157586A patent/JP2026016375A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021535107A5 (https=) | ||
| JP2023519965A5 (https=) | ||
| JP2006506378A5 (https=) | ||
| JP2023541430A5 (https=) | ||
| FI3840753T3 (fi) | Migalastaatti käytettäväksi fabryn taudin hoitomenetelmissä potilailla joilla on gla-geenin mutaatio | |
| ES3060114T3 (https=) | ||
| JP2023516753A5 (https=) | ||
| Plänitz | Comparison of moxonidine and clonidine HCl in treating patients with hypertension | |
| Gupta et al. | Intermittent short duration therapy with fluconazole is effective for tinea capitis | |
| JP2022553888A5 (https=) | ||
| JP2004525940A5 (https=) | ||
| US20050256131A1 (en) | Pharmaceutical active substance combination and the use thereof | |
| JP2025517509A5 (https=) | ||
| EP2830605B1 (en) | A combination medicament comprising phenylephrine and paracetamol | |
| FI4114390T3 (fi) | Menetelmiä fabryn taudin hoitamiseksi potilaissa, joilla on mutaatio gla-geenissä | |
| PT891186E (pt) | Administração nasal de agentes para o tratamento de emese tardia | |
| IE851848L (en) | Propiophenone compound against sexual dysfunction | |
| JP2023531930A5 (https=) | ||
| JP2024525760A5 (https=) | ||
| CN1204881C (zh) | 烯丙胺衍生物在制备治疗幽门螺杆菌感染和相关疾病的药物方面的用途 | |
| US20170087104A1 (en) | Medicament | |
| JP2024531799A5 (https=) | ||
| JP2025521501A5 (https=) | ||
| AU2012276476B2 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| CA2612179A1 (en) | A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion |